導(dǎo)師簡(jiǎn)介

姓名:郎小娥 性別:女政治面貌:民革黨員學(xué)歷:博士研究生畢業(yè)學(xué)位:醫(yī)學(xué)博士職稱(chēng):主任醫(yī)師博、碩導(dǎo)師:博導(dǎo)和碩導(dǎo)本崗位工作年數(shù):40.5年
研究方向:
精神分裂癥與抑郁癥的基礎(chǔ)與臨床研究
榮譽(yù)稱(chēng)號(hào):
(1)山西省“三晉英才-拔尖骨干人才”
(2)獲2023年度山西省科技進(jìn)步二等獎(jiǎng)
(3)獲2019年度山西省科技進(jìn)步二等獎(jiǎng)
(4)2022年度郎小娥以第一發(fā)明人授權(quán)國(guó)際發(fā)明專(zhuān)利1項(xiàng)
學(xué)術(shù)任職:
中華醫(yī)學(xué)會(huì)精神病學(xué)分會(huì)網(wǎng)絡(luò)精神病學(xué)組委員
中國(guó)醫(yī)師協(xié)會(huì)醫(yī)學(xué)科普分會(huì)精神心理專(zhuān)委會(huì)委員
中國(guó)民族衛(wèi)生協(xié)會(huì)心理健康分會(huì)常務(wù)理事
中國(guó)藥物濫用防治協(xié)會(huì)理事
山西省老年醫(yī)學(xué)學(xué)會(huì)精神醫(yī)學(xué)分會(huì)主任委員
山西省精神科專(zhuān)科聯(lián)盟醫(yī)療質(zhì)控中心主任
近五年承擔(dān)科研課題情況:
(1)中央引導(dǎo)地方科技發(fā)展資金項(xiàng)目(自由探索類(lèi)基礎(chǔ)研究),項(xiàng)目名稱(chēng):首發(fā)分裂癥糖代謝紊亂介導(dǎo)“腦SC-FC耦合”異常的機(jī)制研究,項(xiàng)目編號(hào):YDZJSX2022A064,主持
(2)山西省“136興醫(yī)工程”領(lǐng)軍臨床專(zhuān)科專(zhuān)項(xiàng)(136專(zhuān)項(xiàng)),項(xiàng)目名稱(chēng):首發(fā)精神分裂癥海馬體積,、血漿蛋白質(zhì)組分與P50改變之間交互作用的機(jī)制研究,項(xiàng)目編號(hào):Y2022136006,主持
代表性論著及近五年的代表性論文(限10項(xiàng)以?xún)?nèi)):
近五年郎小娥以第一作者和/或通訊作者發(fā)表的10篇SCI代表性論文
[1]Xiaoe Lang,Mei Xue,Xiaocui Zang,Fengchun Wu*,Meihong Xiu*,Xiangyang Zhang*. Efficacy of low-dose risperidone in combination with sertraline in first-episode drug-na?ve patients with schizophrenia: a randomized controlled open-label study [J]. J Transl Med, 2023, 21(1): 432.(唯一第一作者中科院2區(qū)IF:6.1)
[2]Meihong Xiu, Lei Zhao, Qianqian Sun,Xiaoe Lang*. Efficacy of Low-dose Olanzapine in Combination with Sertraline on Negative Symptoms and Psychosocial Functioning in Schizophrenia: A Randomized Controlled Trial [J]. Curr Neuropharmacol, 2024,,22(8):1406-1413.(唯一通訊作者中科院2區(qū)IF:4.8)
[3]Xiaoe Lang*, Dongmei Wang, Dachun Chen, Meihong Xiu, Huixia Zhou, Li Wang, Bo Cao*, Xiangyang Zhang*. Association Between Hippocampal Subfields and Clinical Symptoms of First-Episode and Drug Naive Schizophrenia Patients During 12 Weeks of Risperidone Treatment [J]. Neurotherapeutics, 2022, 19(1): 399-407.(唯一第一作者/共同通訊作者中科院2區(qū)IF:5.7)
[4] Meihong Xiu, Meng Hao, Cai Liu, Maodi Sun,Xiaoe Lang*.Glucose Metabolism and Sex Hormones in Male Patients with Medication-na?ve First-episode Schizophrenia: A Large-scale Cross-sectional Study[J].Curr Neuropharmacol, 2024;22(13):2263-2270.(唯一通訊作者中科院2區(qū)IF:4.8)
[5] Meihong Xiu, Wenxin Li, Yu Lan, Kaiwen Li,Xiaoe Lang*. Differentiation Across Bipolar Disorder and Major Depressive Disorder by Whole-Night Polysomnographic Findings. J Clin Psychiatry, 2024 ,14;85(3):23m15210.(唯一通訊作者中科院2區(qū)IF:4.5)
[6]Xiaoe Lang,Xiaocui Zang, Feng Yu, Meihong Xiu*. Effects of low-dose combined olanzapine and sertraline on negative and depressive symptoms in treatment-resistant outpatients with acute exacerbated schizophrenia [J]. Front Pharmacol, 2023, 14(1166507.(唯一第一作者中科院2區(qū)IF:4.4)
[7]Mei Hong Xiu,XiaoE Lang*, Da Chun Chen, Bo Cao, Thomas R. Kosten,Raymond Y. Cho, Hui Shi, Chang Wei Wei, An Shi Wu, Xiang Yang Zhang*.Cognitive Deficits and Clinical Symptoms with Hippocampal Subfields in First-Episode and Never-Treated Patients with Schizophrenia [J]. Cereb Cortex, 2021, 31(1): 89-96.(共同通訊作者中科院2區(qū)IF:4.861)
[8]Xiaoe Lang, Yang Zhou, Lei Zhao, Yinjun Gu, Xi Wu, Yuefeng Zhao, Zezhi Li*, Xiangyang Zhang*.Differences in patterns of metabolic abnormality and metabolic syndrome between early-onset and adult-onset first-episode drug-naive schizophrenia patients [J]. Psychoneuroendocrinology, 2021, 132(105344.(唯一第一作者中科院2區(qū)IF:4.693)
[9]Xiaoe Lang*, Dongmei Wang, Huixia Zhou, Li Wang, Thomas R. Kosten, Xiang-Yang Zhang*.P50 inhibition defects, psychopathology and gray matter volume in patients with first-episode drug-naive schizophrenia [J]. Asian J Psychiatr, 2023, 80(103421.(唯一第一作者/共同通訊作者中科院4區(qū)IF:9.5)
[10]Xiaoe Lang, Qinqin Liu, Hanliu Fang, Yongjie Zhou, Mattew T. Forster, Zezhi Li*, Xiangyang Zhang*.The prevalence and clinical correlates of metabolic syndrome and cardiometabolic alterations in 430 drug-naive patients in their first episode of schizophrenia [J]. Psychopharmacology, 2021, 238(12): 3643-52.(唯一第一作者中科院3區(qū)IF:4.415)